LINC02169

Across TCGA pan-cancer cohorts, LINC02169 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC02169 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher LINC02169 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02169 expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

CHOL, READ, and UCEC are the cancer types where LINC02169 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.248	0.770	<.001	144	view →
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	96	view →
UCEC	DFS	Tertile	All	0.804	0.906	.006	60	view →
LGG	DFS	Tertile	All	0.462	0.755	<.001	45	view →
THCA	OS	Tertile	All	0.652	0.953	<.001	36	view →
LUAD	DFS	Tertile	All	0.809	0.621	.018	33	view →
COAD	OS	Tertile	All	0.176	0.682	.001	30	view →
LUSC	OS	Tertile	III,IV	0.054	0.768	<.001	18	view →
STAD	DFS	Tertile	IV	0.160	0.402	.044	9	view →
OV	OS	Tertile	II,III,IV	0.582	0.697	.047	6	view →
KIRC	OS	Quartile	II,III,IV	0.414	0.568	.022	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC02169–CHOL (OS)

Open the CHOL breakdown →